2010
DOI: 10.5483/bmbrep.2010.43.11.738
|View full text |Cite
|
Sign up to set email alerts
|

Molecular cloning and characterization of novel human JNK2 (MAPK9) transcript variants that show different stimulation activities on AP-1

Abstract: The c-Jun NH2-terminal kinase (JNK) signaling pathway participates in many physiological functions. In the current study we reported the cloning and characterization of five novel JNK2 transcript variants, which were designated as JNK2α3, JNK2α4,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 20 publications
0
9
0
Order By: Relevance
“…The overexpression of MAPK induced cell migration and invasion, a morphologic change in EMT. The lack of MAPK increasing tumor aneuploidy and reduced DNA damage [35-40]. …”
Section: Discussionmentioning
confidence: 99%
“…The overexpression of MAPK induced cell migration and invasion, a morphologic change in EMT. The lack of MAPK increasing tumor aneuploidy and reduced DNA damage [35-40]. …”
Section: Discussionmentioning
confidence: 99%
“…JNK comprises a family of three JNK subtypes, JNK1, JNK2 and JNK3, and the three JNK genes; jnk1 , jnk2 and jnk3 encode more than 10 different isoforms [16], [17]. Despite high JNK isoform homology the JNK subtypes have differential functions depending of cellular context and stimuli [18], [19].…”
Section: Introductionmentioning
confidence: 99%
“…Highly enriched KEGG pathway analysis indicated that MAPK9 and Dusp2 may serve a role through the MAPK signaling pathway, which is involved in a number of cellular functions, such as differentiation, proliferation and cell death (27). Of these, the physiological functions of MAPK9 [(also known as c-Jun N-terminal kinase 2 (JNK2)] in osteodifferentiation and bone formation have been investigated previously (28). MAPK9 activity is essential for the expression of activating transcription factor 4, and its overexpression may enhance mineral deposition that is essential in the late stages osteogenic differentiation (29).…”
Section: Discussionmentioning
confidence: 99%